Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,025 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Hertzberg M, Gandhi MK, Trotman J, Butcher B, Taper J, Johnston A, Gill D, Ho SJ, Cull G, Fay K, Chong G, Grigg A, Lewis ID, Milliken S, Renwick W, Hahn U, Filshie R, Kannourakis G, Watson AM, Warburton P, Wirth A, Seymour JF, Hofman MS, Hicks RJ; Australasian Leukaemia Lymphoma Group (ALLG). Hertzberg M, et al. Among authors: gill d. Haematologica. 2017 Feb;102(2):356-363. doi: 10.3324/haematol.2016.154039. Epub 2016 Nov 10. Haematologica. 2017. PMID: 28143954 Free PMC article. Clinical Trial.
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.
Keane C, Vari F, Hertzberg M, Cao KA, Green MR, Han E, Seymour JF, Hicks RJ, Gill D, Crooks P, Gould C, Jones K, Griffiths LR, Talaulikar D, Jain S, Tobin J, Gandhi MK. Keane C, et al. Among authors: gill d. Lancet Haematol. 2015 Oct;2(10):e445-55. doi: 10.1016/S2352-3026(15)00150-7. Epub 2015 Oct 1. Lancet Haematol. 2015. PMID: 26686046 Clinical Trial.
Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
Bradstock KF, Link E, Di Iulio J, Szer J, Marlton P, Wei AH, Enno A, Schwarer A, Lewis ID, D'Rozario J, Coyle L, Cull G, Campbell P, Leahy MF, Hahn U, Cannell P, Tiley C, Lowenthal RM, Moore J, Cartwright K, Cunningham I, Taper J, Grigg A, Roberts AW, Benson W, Hertzberg M, Deveridge S, Rowlings P, Mills AK, Gill D, Bardy P, Campbell L, Seymour JF; Australasian Leukaemia & Lymphoma Group. Bradstock KF, et al. Among authors: d rozario j, gill d. J Clin Oncol. 2017 May 20;35(15):1678-1685. doi: 10.1200/JCO.2016.70.6374. Epub 2017 Apr 3. J Clin Oncol. 2017. PMID: 28368672 Clinical Trial.
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia.
Iland H, Bradstock K, Seymour J, Hertzberg M, Grigg A, Taylor K, Catalano J, Cannell P, Horvath N, Deveridge S, Browett P, Brighton T, Chong L, Springall F, Ayling J, Catalano A, Supple S, Collins M, Di Iulio J, Reynolds J; Australasian Leukaemia and Lymphoma Group. Iland H, et al. Haematologica. 2012 Feb;97(2):227-34. doi: 10.3324/haematol.2011.047506. Epub 2011 Oct 11. Haematologica. 2012. PMID: 21993673 Free PMC article. Clinical Trial.
Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma.
Grigg AP, Stone J, Milner AD, Schwarer AP, Wolf M, Prince HM, Seymour J, Gill D, Ellis D, Bashford J; Australasian Leukaemia & Lymphoma Group. Grigg AP, et al. Among authors: gill d. Leuk Lymphoma. 2010 Apr;51(4):641-9. doi: 10.3109/10428191003611428. Leuk Lymphoma. 2010. PMID: 20218809 Clinical Trial.
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
Mulligan SP, Karlsson K, Strömberg M, Jønsson V, Gill D, Hammerström J, Hertzberg M, McLennan R, Uggla B, Norman J, Wallvik J, Sundström G, Johansson H, Brandberg Y, Liliemark J, Juliusson G; Scandinavian and Australasian Leukaemia Lymphoma Groups (Allg). Mulligan SP, et al. Among authors: gill d. Leuk Lymphoma. 2014 Dec;55(12):2769-77. doi: 10.3109/10428194.2014.893306. Epub 2014 Apr 16. Leuk Lymphoma. 2014. PMID: 24524339 Clinical Trial.
Epstein-Barr virus T-cell immunity despite rituximab.
Nehring AK, Dua U, Mollee P, Gill D, Grimmett K, Khanna R, Moss D, Gandhi MK. Nehring AK, et al. Among authors: gill d. Br J Haematol. 2007 Feb;136(4):628-32. doi: 10.1111/j.1365-2141.2006.06482.x. Br J Haematol. 2007. PMID: 17223914 Clinical Trial.
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Barrientos JC, O'Brien S, Brown JR, Kay NE, Reddy NM, Coutre S, Tam C, Mulligan S, Jaeger U, Devereux S, Pocock C, Robak T, Schuster SJ, Schuh A, Gill D, Bloor A, Dearden C, Moreno C, Cull G, Hamblin M, Jones JA, Eckert K, Solman IG, Suzuki S, Hsu E, James DF, Byrd JC, Hillmen P. Barrientos JC, et al. Among authors: gill d. Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):803-813.e7. doi: 10.1016/j.clml.2018.08.007. Epub 2018 Aug 18. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30249389 Free PMC article. Clinical Trial.
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial.
Moreno C, Greil R, Demirkan F, Tedeschi A, Anz B, Larratt L, Simkovic M, Novak J, Strugov V, Gill D, Gribben JG, Kwei K, Dai S, Hsu E, Dean JP, Flinn IW. Moreno C, et al. Among authors: gill d. Haematologica. 2022 Sep 1;107(9):2108-2120. doi: 10.3324/haematol.2021.279012. Haematologica. 2022. PMID: 35021599 Free PMC article. Clinical Trial.
A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.
Bradstock KF, Matthews JP, Lowenthal RM, Baxter H, Catalano J, Brighton T, Gill D, Eliadis P, Joshua D, Cannell P, Schwarer AP, Durrant S, Gillett A, Koutts J, Taylor K, Bashford J, Arthur C, Enno A, Dunlop L, Szer J, Leahy M, Juneja S, Young GA; Australasian Leukaemia and Lymphoma Group. Bradstock KF, et al. Among authors: gill d. Blood. 2005 Jan 15;105(2):481-8. doi: 10.1182/blood-2004-01-0326. Epub 2004 Jun 22. Blood. 2005. PMID: 15213095 Free article. Clinical Trial.
Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia.
Maung KZY, Leo PJ, Bassal M, Casolari DA, Gray JX, Bray SC, Pederson S, Singhal D, Samaraweera SE, Nguyen T, Cildir G, Marshall M, Ewing A, Duncan EL, Brown MA, Saal R, Tergaonkar V, To LB, Marlton P, Gill D, Lewis I, Deans AJ, Brown AL, D'Andrea RJ, Gonda TJ. Maung KZY, et al. Among authors: d andrea rj, gill d. Blood Cancer J. 2018 Jun 1;8(6):50. doi: 10.1038/s41408-018-0090-7. Blood Cancer J. 2018. PMID: 29891941 Free PMC article. No abstract available.
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG).
Lowenthal RM, Bradstock KF, Matthews JP, Bishop JF, Juneja S, Cobcroft R, Eliadis P, Enno A, Gill D, Herrmann RP, Manoharan A, Page FJ, Rooney KF, Rosenfeld D, Seldon M, Taylor KM, Wolf MM, Young GA. Lowenthal RM, et al. Among authors: gill d. Leuk Lymphoma. 1999 Aug;34(5-6):501-10. doi: 10.3109/10428199909058477. Leuk Lymphoma. 1999. PMID: 10492073 Clinical Trial.
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Moreno C, Greil R, Demirkan F, Tedeschi A, Anz B, Larratt L, Simkovic M, Samoilova O, Novak J, Ben-Yehuda D, Strugov V, Gill D, Gribben JG, Hsu E, Lih CJ, Zhou C, Clow F, James DF, Styles L, Flinn IW. Moreno C, et al. Among authors: gill d. Lancet Oncol. 2019 Jan;20(1):43-56. doi: 10.1016/S1470-2045(18)30788-5. Epub 2018 Dec 3. Lancet Oncol. 2019. PMID: 30522969 Clinical Trial.
A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Tedeschi A, Greil R, Demirkan F, Robak T, Moreno C, Barr PM, Anz B, Simpson D, Gaidano G, Bairey O, Stevens D, Gill D, Flinn IW, Kipps TJ, Burger JA, Lin J, Webb T, Fedorov V, Styles L, Gribben JG. Tedeschi A, et al. Among authors: gill d. Haematologica. 2020 Apr;105(4):e164-e168. doi: 10.3324/haematol.2019.223743. Epub 2019 Aug 14. Haematologica. 2020. PMID: 31413095 Free PMC article. Clinical Trial. No abstract available.
Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia.
Bradstock K, Matthews J, Young G, Lowenthal R, Baxter H, Arthur C, Bashford J, Brighton T, Cannell P, Dunlop L, Durrant S, Enno A, Eliadis P, Gill D, Gillett A, Gottlieb D, Januszewicz H, Joshua D, Leahy M, Schwarer A, Taylor K; Australian Leukaemia Study Group. Bradstock K, et al. Among authors: gill d. Leukemia. 2001 Sep;15(9):1331-8. doi: 10.1038/sj.leu.2402218. Leukemia. 2001. PMID: 11516093 Clinical Trial.
The duality of macrophage function in chronic lymphocytic leukaemia.
Chen YCE, Mapp S, Blumenthal A, Burgess ML, Mazzieri R, Mattarollo SR, Mollee P, Gill D, Saunders NA. Chen YCE, et al. Among authors: gill d. Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):176-182. doi: 10.1016/j.bbcan.2017.03.006. Epub 2017 Mar 24. Biochim Biophys Acta Rev Cancer. 2017. PMID: 28347751 Review.
Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression.
Vuckovic S, Kim M, Khalil D, Turtle CJ, Crosbie GV, Williams N, Brown L, Williams K, Kelly C, Stravos P, Rodwell R, Hill GR, Wright S, Taylor K, Gill D, Marlton P, Bradstock K, Hart DN. Vuckovic S, et al. Among authors: gill d. Blood. 2003 Mar 15;101(6):2314-7. doi: 10.1182/blood-2002-03-0973. Epub 2002 Oct 24. Blood. 2003. PMID: 12406901 Free article.
CD62L as a therapeutic target in chronic lymphocytic leukemia.
Burgess M, Gill D, Singhania R, Cheung C, Chambers L, Renyolds BA, Smith L, Mollee P, Saunders N, McMillan NA. Burgess M, et al. Among authors: gill d. Clin Cancer Res. 2013 Oct 15;19(20):5675-85. doi: 10.1158/1078-0432.CCR-13-1037. Epub 2013 Aug 15. Clin Cancer Res. 2013. PMID: 23948971
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.
Greil R, Tedeschi A, Moreno C, Anz B, Larratt L, Simkovic M, Gill D, Gribben JG, Flinn IW, Wang Z, Cheung LWK, Nguyen AN, Zhou C, Styles L, Demirkan F. Greil R, et al. Among authors: gill d. Ann Hematol. 2021 Jul;100(7):1733-1742. doi: 10.1007/s00277-021-04536-6. Epub 2021 May 20. Ann Hematol. 2021. PMID: 34018029 Free PMC article. Clinical Trial.
Loss of PKR activity in chronic lymphocytic leukemia.
Hii SI, Hardy L, Crough T, Payne EJ, Grimmett K, Gill D, McMillan NA. Hii SI, et al. Among authors: gill d. Int J Cancer. 2004 Apr 10;109(3):329-35. doi: 10.1002/ijc.11714. Int J Cancer. 2004. PMID: 14961569
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Schuster SJ, Montillo M, Schuh A, de Vos S, Gill D, Bloor A, Dearden C, Moreno C, Jones JJ, Chu AD, Fardis M, McGreivy J, Clow F, James DF, Hillmen P; RESONATE Investigators. Byrd JC, et al. Among authors: gill d. N Engl J Med. 2014 Jul 17;371(3):213-23. doi: 10.1056/NEJMoa1400376. Epub 2014 May 31. N Engl J Med. 2014. PMID: 24881631 Free PMC article. Clinical Trial.
Epidemiology and pharmacological management of new onset atrial fibrillation in critically ill adults: A multicentre observational study.
Denny KJ, Whebell S, McCullough JPA, Laupland KB, Blank S, Tabah A, Shekar K, Garrett P, Ramanan M, Attokaran AG, Raith E, Walker HGM, Brown A, White KC; Queensland Critical Care Research Network (QCCRN). Denny KJ, et al. Crit Care Resusc. 2026 Feb 19;28(1):100162. doi: 10.1016/j.ccrj.2026.100162. eCollection 2026 Mar. Crit Care Resusc. 2026. PMID: 41767639 Free PMC article.
The Ocean Equity Index.
Blythe JL, Claudet J, Gill D, Ban NC, Epstein G, Gurney GG, Jupiter SD, Mahajan SL, Mangubhai S, Turner R, Bennett NJ, D'Agata S, Franks P, Lau J, Ahmadia G, Andrachuk M, Annasawmy P, Brun V, Darling ES, Di Franco A, Evans L, Lazzari N, Naggea J, Relano V, Pertuz MC, Villasante S, Zafra-Calvo N. Blythe JL, et al. Among authors: gill d. Nature. 2026 Feb;650(8100):123-128. doi: 10.1038/s41586-025-09976-y. Epub 2026 Jan 28. Nature. 2026. PMID: 41606346 Free PMC article.
Cross-ancestry comparison of aptamer and antibody protein measures.
Nicholas JC, Katz DH, Tahir UA, Debban CL, Aguet F, Blackwell T, Bowler RP, Broadaway KA, Chen J, Clish CB, Coresh J, Cornell E, Cruz DE, Deo R, Doyle MF, Durda P, Ekunwe L, Floyd JS, Gill D, Guo X, Hoogeveen RC, Johnson C, Lange LA, Li Y, Manning A, Meigs JB, Mi MY, Mychaleckyj JC, Olson NC, Pratte KA, Psaty BM, Reiner AP, Ruan P, Sevilla-Gonzalez M, Shah AM, Sun Q, Tracy RP, Wen J, Wood AC, Wilson JG, Young KL, Yu B, Rooney MR, Manichaikul A, Dubin R, Mohlke KL, Rich SS, Rotter JI, Ganz P, Gerszten RE, Taylor KD, Raffield LM. Nicholas JC, et al. Among authors: gill d. Nat Commun. 2026 Jan 22;17(1):1054. doi: 10.1038/s41467-025-67814-1. Nat Commun. 2026. PMID: 41571639 Free PMC article.
Bilateral frontal periventricular nodular heterotopia: a distinctive cortical malformation.
Hoogwijs I, Mandelstam SA, McGillivray G, Halliday BJ, Yiu EM, Macdonald-Laurs E, Perry D, Patel R, Gabbett M, Patel C, Malone S, Fahey M, Gill D, Field M, Delatycki MB, Mohammad S, Berkovic SF, Scheffer IE, Lockhart PJ, Jackson GD, Jansen AC, Robertson SP, Leventer RJ. Hoogwijs I, et al. Among authors: gill d. Eur J Paediatr Neurol. 2025 Dec 29;60:78-85. doi: 10.1016/j.ejpn.2025.12.004. Online ahead of print. Eur J Paediatr Neurol. 2025. PMID: 41468712
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors.
Gill D, Cowey CL, Daniels GA, Sommerhalder D, Abdul-Karim R, Kirkwood JM, Kolodney J, Mehmi I, Roberts-Thomson R, Strauss J, Thomas S, Whitman E, Xing Y, McKean M, Collins S, Li C, Saggu G, Chen T, Wang S, Lewis M, Parot X, Johnson M. Gill D, et al. Front Oncol. 2025 Dec 8;15:1620987. doi: 10.3389/fonc.2025.1620987. eCollection 2025. Front Oncol. 2025. PMID: 41445795 Free PMC article.
Recombination Suppression Drives Expansion of the Drosophila Dot Chromosome.
Stanek TJ, Leung W, Shaffer CD; Genomics Education Partnership; Olaveja I, Laughlin A, Hester J, Garrido D, Oh EK, Volski M, Panda N, Mo M, Cordes E, Dalling M, Kershaw K, Arnott M, Daly S, Valenzuela SG, Thompson P, Hastert KL, Sabb D, Karpinski K, Arora MN, Rius N, LoBello L, Jaramillo S, Sonavane O, Herrmann A, Reed LK, Elgin SCR, Arrigo C, Ellison CE. Stanek TJ, et al. Mol Biol Evol. 2025 Nov 28;42(12):msaf304. doi: 10.1093/molbev/msaf304. Mol Biol Evol. 2025. PMID: 41442496 Free PMC article.
Deep tissue sequencing improves genetic diagnostic yield in focal cortical dysplasia.
Galea B, Reid J, Gooley S, Witkowski T, Lane T, Macdonald S, Green TE, Ye Z, Adikari T, Bulluss K, Mullen SA, Bennett CA, Forster B, Bradshaw G, Lin W, De Silva W, Ramirez RB, Khoshkhoo S, Gupta S, Krivanek M, Kothur K, Gill D, Pope K, Gillies G, Coleman M, Lee WS, Stephenson SM, Maixner W, Harvey AS, Macdonald-Laurs E, Howell KB, D'Arcy C, Lockhart PJ, Leventer RJ, Kalnins RM, Clark J, Bennett MF, Bahlo M, Scheffer IE, Perucca P, Berkovic SF, Hildebrand MS. Galea B, et al. Among authors: gill d, d arcy c. medRxiv [Preprint]. 2025 Nov 22:2025.11.17.25340194. doi: 10.1101/2025.11.17.25340194. medRxiv. 2025. PMID: 41332841 Free PMC article. Preprint.
Scaling up actionable climate knowledge.
Lemos MC, Maillard L, Herbert N, Domingue SJ, Jagannathan K, Wong-Parodi G, Goto EA, Gill D, Van Berkel D, Kalafatis S, Jorns JL, Basaraba A, Harrison T. Lemos MC, et al. Among authors: gill d. Proc Natl Acad Sci U S A. 2025 Dec 16;122(50):e2515771122. doi: 10.1073/pnas.2515771122. Epub 2025 Nov 26. Proc Natl Acad Sci U S A. 2025. PMID: 41296697 Free PMC article.
Partial Oral Versus Intravenous Antibiotic Therapy for Endocarditis With Management by a Multidisciplinary Team: A Retrospective Cohort Study.
El-Dalati S, Collis B, Kobayashi T, Hall E, Alnabelsi T, Cao C, Johnson M, Gurley J, Strnad L, Adams C, Weaver V, Reda H, Sekela M, London T, Kennedy K, Mansoor AR, Olafsson D, Laugherty G, Tremblay A, Linder A, Gill D, Van Sickels NJ, Pomakov A, Harris W, Stoner BJ. El-Dalati S, et al. Among authors: gill d. Open Forum Infect Dis. 2025 Oct 28;12(10):ofaf625. doi: 10.1093/ofid/ofaf625. eCollection 2025 Oct. Open Forum Infect Dis. 2025. PMID: 41164785 Free PMC article.
Outcomes of pyrolytic carbon humeral resurfacing hemiarthroplasty compared to best-in-class total shoulder arthroplasty in young patients with osteoarthritis: analysis from the Australian Orthopaedic Association National Joint Replacement Registry.
McBride A, Hurley R, Gill D, Du P, Duke P, Taylor F, Hoy G, Page R, Ross M. McBride A, et al. Among authors: gill d. J Shoulder Elbow Surg. 2025 Oct 23:S1058-2746(25)00752-9. doi: 10.1016/j.jse.2025.09.007. Online ahead of print. J Shoulder Elbow Surg. 2025. PMID: 41139005
Author Correction: Cross-population GWAS and proteomics improve risk prediction and reveal mechanisms in atrial fibrillation.
Yuan S, Chen J, Ruan X, Li Y, Abramowitz SA, Wang L, Jiang F, Xiong Y, Levin MG, Voight BF, Gill D, Burgess S, Åkesson A, Michaëlsson K, Li X, Damrauer SM, Larsson SC. Yuan S, et al. Among authors: gill d. Nat Commun. 2025 Oct 3;16(1):8811. doi: 10.1038/s41467-025-64765-5. Nat Commun. 2025. PMID: 41044100 Free PMC article. No abstract available.
Accounting for human-nature linkages in area-based conservation monitoring through social-ecological indicator bundles.
Ban NC, Carr MH, Rubidge EM, Salomon A, Claudet J, Levine A, Aylesworth L, Ramirez L, Burt JM, Andrachuk M, Tamburello N, Martone R, Schuhbauer A, Meehan M, Baker D, Gurney GG, Bennett NJ, Gill D, Singh G, Gelcich S, Maloney A, Beaty F. Ban NC, et al. Among authors: gill d. Conserv Biol. 2025 Dec;39(6):e70156. doi: 10.1111/cobi.70156. Epub 2025 Sep 29. Conserv Biol. 2025. PMID: 41021576 Free PMC article.
Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways.
Vujkovic M, Kaplan DE, Ghouse J, Loza BL, Brancale J, Lewis A, Zhang DY, Levin MG, Veatch OJ, Johnson JP, Schneider CV, Verma A, Wangensteen KJ, Scorletti E, Gill D, Konkwo C, Garófalo AM, Guare LA, Schwantes-An TW, Abreu MV, Gellert-Kristensen H, Pedersen OB, Erikstrup C, Bundgaard JS, Sørensen E, Ostrowski SR, Bundgaard H, Lee KM, Shaked A, Olthoff KM, Hoteit MA, Speliotes EK, Chen Y, Oliveri A, Yin L, Valenti LV, Malvestiti F, Marchelli D, Miano L, Anstee QM, Daly AK, Cordell HJ, Darlay R, Verweij N, Hindy G, Locke A, Matsuura K, Asrani SK, Testa G, Lotta LA, Jones MB, Dochtermann DR, Norden-Krichmar TM, Teerlink CC, Devineni P, Pyarajan S, Rader DJ, Tanaka Y, Voight BF, Vilarinho S, Bastarache LA, Stender S, Tsao PS; Penn Medicine Biobank; DBDS Genomic Consortium; BioVU Biobank; Michigan Genomics Initiative; Regeneron Genetics Center; Indiana Biobank; All Of Us Research Program; Milano Biobank; LITMUS Consortium; VA Million Veteran Program; Morgan TR, Lynch JA, Chang KM. Vujkovic M, et al. Among authors: gill d. medRxiv [Preprint]. 2025 Sep 18:2025.09.16.25335186. doi: 10.1101/2025.09.16.25335186. medRxiv. 2025. PMID: 41001506 Free PMC article. Preprint.
2,025 results